Gossamer Bio, Inc. (GOSS)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenue | 11,489 | 9,889 | 9,480 | 95,842 |
| Research and development | 41,575 | 38,041 | 34,897 | 35,086 |
| General and administrative | 8,679 | 8,658 | 8,502 | 8,669 |
| Total operating expenses | 50,254 | 46,699 | 43,399 | 43,755 |
| Income (loss) from operations | -38,765 | -36,810 | -33,919 | 52,087 |
| Other income, net | 2,694 | 2,624 | 4,288 | 2,747 |
| Interest income | 542 | 294 | 430 | 1,749 |
| Interest expense | 2,744 | 2,746 | 2,734 | 2,916 |
| Total other income, net | 492 | 172 | 1,984 | 1,580 |
| Income (loss) before provision for income taxes | -38,273 | - | -31,935 | 53,667 |
| Provision for income taxes | - | - | -1,132 | 4,435 |
| Net income (loss) | -38,273 | -36,638 | -30,803 | 49,232 |
| Unrealized loss on marketable securities | -69 | -110 | 547 | -25 |
| Foreign currency translation | -4,195 | -1,903 | -2,260 | 135 |
| Other comprehensive income (loss) | -4,264 | -2,013 | -1,713 | 110 |
| Comprehensive income (loss) | -42,537 | -38,651 | -32,516 | 49,342 |
| Net income (loss) per share, basic (in dollars per share) | -0.17 | -0.16 | -0.14 | 0.22 |
| Net income (loss) per share, diluted (in dollars per share) | -0.17 | -0.16 | -0.14 | 0.22 |
| Weighted average common shares outstanding, basic (in shares) | 227,275,466 | 226,818,051 | 226,346,058 | 226,221,202 |
| Weighted average common shares outstanding, diluted (in shares) | 227,275,466 | 226,818,051 | 226,346,058 | 238,543,102 |